Study of Physiological Signals During and After COPD Exacerbations
DACRE
Collecte de données Physiologiques en Continu Chez Des Patients en Insuffisance Respiratoire Pendant et après un épisode d'Exacerbation de BPCO
1 other identifier
interventional
42
1 country
1
Brief Summary
Background : Acute exacerbations of COPD (Chronic Obstructive Pulmonary Disease) are frequent events in the course of the disease and they can deteriorate the respiratory function of the patients, impact their quality of life and even potentially threaten their life. It is therefore crucial to prevent these exacerbations from occurring. Aim of the study : Investigate how cardiorespiratory parameters of COPD patients differ between exacerbation phases and their nominal state in order to identify predictors of COPD exacerbations. Study design : Patients admitted at one of the investigation centers on a suspicion of COPD exacerbation will be enrolled on a voluntary basis. Enrolled patients' cardiorespiratory parameters will be monitored with a connected wrist-worn pulse oximeter (BORA Band) during the hospitalisation phase and one month after they have been discharged. Setting : 4 investigative centers across Brittany Patients : 50 patients will be enrolled in the study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2019
CompletedFirst Posted
Study publicly available on registry
July 26, 2019
CompletedStudy Start
First participant enrolled
February 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 6, 2024
CompletedAugust 15, 2024
August 1, 2024
3 years
June 28, 2019
August 14, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Variation of heart rate during and after a COPD acute exacerbation
Average heart rate in beats per minute during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter
2 months
Variation of respiratory rate during and after a COPD acute exacerbation
Average respiratory rate in cycles per minute during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter
2 months
Variation of SpO2 during and after a COPD acute exacerbation
Average SpO2 in percent during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter
2 months
Variation of skin temperature during and after a COPD acute exacerbation
Average skin temperature in celcius during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter
2 months
Variation of patient activity during and after a COPD acute exacerbation
Average patient activity measured in activity duration per day during and after COPD exacerbation will be assessed thanks to a wrist-worn connected pulse oximeter
2 months
Secondary Outcomes (2)
Connected wrist-worn pulse oximeter adherence
2 months
Patient satisfaction
2 months
Study Arms (1)
Monitoring of cardiorespiratory parameters
EXPERIMENTALMonitoring of cardiorespiratory parameters with BORA Band
Interventions
The subjects will continuously wear a connected wrist-worn pulse oximeter which will remotely collect the following measurements : * Activity * Step count * Heart rate * Respiratory rate * Skin temperature * SpO2
Eligibility Criteria
You may qualify if:
- patient known or suspected to suffer from COPD
- patient admitted in pulmonology unit for COPD exacerbation
- patient accepting to use BORA Band during and after hospitalization
- patient accepting to be followed by the partner health care provider for this study (Air de Bretagne)
- patient able to understand French and express their informed consent
- patient affiliated to social security
You may not qualify if:
- patient is intubated
- patient already followed by a health care provider other than Air de Bretagne
- investigator assesses that the patient will have difficulties following the protocol
- patient already enrolled in another interventional study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Biosencylead
- Slb Pharmacollaborator
- Air de Bretagnecollaborator
- Rennes University Hospitalcollaborator
- Centre Hospitalier Bretagne Atlantiquecollaborator
- Centre Hospitalier de Saint-Malocollaborator
- Centre Hospitalier de Saint-Brieuccollaborator
Study Sites (1)
Chru Pontchaillou
Rennes, 35000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Graziella Brinchault, M.D.
CHU Rennes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2019
First Posted
July 26, 2019
Study Start
February 19, 2021
Primary Completion
February 6, 2024
Study Completion
February 6, 2024
Last Updated
August 15, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share